Zacks Investment Research upgraded shares of LIPOSCIENCE INC (LPDX) from NEUTRAL to OUTPERFORM on April 11, 2014, with a target price of $3.30.
LipoScience, Inc. is an in vitro diagnostic company developing personalized diagnostics based on nuclear magnetic resonance, or NMR, technology. The Company's first proprietary product based on its NMR spectroscopy technology is its NMR Lipoprofile(R) test, which measures the number of low density lipoprotein particles (LDL-P) in a blood sample. LipoScience, Inc. is headquartered in Raleigh, North Carolina.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on LIPOSCIENCE INC (LPDX),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment